Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Expert Review of Vaccines|March 8, 2023
Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children in IndiaHitt J Sharma, Sameer Parekh, Pramod Pujari, et al.
The Lancet. Oncology|November 10, 2023
Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9-14 years versus an established quadrivalent HPV vaccine in women aged 15-26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trialHitt Sharma, Sameer Parekh, Pramod Pujari, et al.
Vaccine|October 3, 2017
A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infantsPrasad S Kulkarni, Sajjad Desai, Tushar Tewari, et al.
Lancet (London, England)|March 18, 2014
Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trialNita Bhandari, Temsunaro Rongsen-Chandola, Ashish Bavdekar, et al.
Vaccine|August 6, 2014
Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of lifeNita Bhandari, Temsunaro Rongsen-Chandola, Ashish Bavdekar, et al.
NPJ Vaccines|February 21, 2024
A phase III randomized-controlled study of safety and immunogenicity of DTwP-HepB-IPV-Hib vaccine (HEXASIIL<sup>®</sup>) in infantsHitt Sharma, Sameer Parekh, Pramod Pujari, et al.
Vaccine|November 14, 2018
A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infantsNiraj Rathi, Sajjad Desai, Anand Kawade, et al.
Vaccine|April 9, 2019
Immunogenicity and lot-to-lot consistency of a ready to use liquid bovine-human reassortant pentavalent rotavirus vaccine (ROTASIIL - Liquid) in Indian infantsAnand Kawade, Sudhir Babji, Veena Kamath, et al.
Vaccine|August 15, 2018
Non-interference of Bovine-Human reassortant pentavalent rotavirus vaccine ROTASIIL® with the immunogenicity of infant vaccines in comparison with a licensed rotavirus vaccineSajjad Desai, Niraj Rathi, Anand Kawade, et al.
The Lancet. Infectious Diseases|November 9, 2024
Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine versus a quadrivalent meningococcal conjugate vaccine in adults in India: an observer-blind, randomised, active-controlled, phase 2/3 studyPrasad S Kulkarni, Anand Kawade, Sunil Kohli, et al.
Pageof 4